- Dit evenement is voorbij.
Company says it successfully implanted a implantable brain–computer interface in a human
On January 29, 2024, Musk announced that Neuralink had successfully implanted a implantable brain–computer interface in a human, on the day prior.
Musk reported that the unknown (unidentified) patient was recovering well from the surgery. Musk also stated that intial results were showing “promising neuron spike detection”. Neuralink received FDA approval for human clinical trials in May 2023. The FDA had previously rejected a 2022 application to pursue human clinical trials citing “major safety concerns involving the device’s lithium battery; the potential for the implant’s tiny wires to migrate to other areas of the brain; and questions over whether and how the device can be removed without damaging brain tissue.” In September 2023, Neuralink opened up its first human trials for recruitment under an investigational device exemption by the FDA.
Links:
Human testing